1Carreras E,Bertz H,Arcese W,et al.Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation:a prospective cohort study of the European group for blood and marrow transplantation[ J].Blood,1998,10(2):3599 -604.
2Bearman S L.The syndrome of hepatic veno-occlusive disease after marrow transplantation[ J ].Blood,1995,85:3005 -20.
4Lee JH,Choi SJ,Lee JH,et al.VOD Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous Busulfan vs oral Busulfan in adults conditioned with Busulfan + cyclophosphamide for allogeneic bone marrow transplantation[ J ].Ann Hematol,2005,84(5):321-30.
7Je-Hwan Lee,Kyoo-Hyung Lee,Jung-Hee Lee,et al.Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide[ J ].British Journal of Haematology,2002,118 (6):1087 -94.
9Satori MT,Spiezia L,Cesaro S,et al.Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population[ J ].Thromb Haemost,2005,93 (4):682-9.
10Attal M,Huguer F,Robie H,et al.Prevention of hepatic Veno-occlusive desease after bone marrow transplantation by continuous infusion of low dose heparin[ J ].Blood,1992,79(9):2834.
4Shulman H M. Hepatic veno-occlusive disease liver toxicity syndrome after bone marrow transplantion[J]. Bone Marrow Transplant, 1992, 10: 197.
5McDonald G B. The clinical course of 53 patients with venoocclusive disease of liver after bone marrow transplantion[J].Transplant, 1985, 39:603.
6Baglin T P. Veno-occlusive disease of liver complication bone marrow transplantion [J]. Bone Marrow Transplant, 1996,13: 1.
7McDonald G B. Veno-occlusive disease of liver and multiorgan failure after bone marrow transplantion, a cohort study of 355 patients[J]. Ann Inter Med, 1993, 118, 255.
8Rozman C. Risk factor for hepatic veno-ocelusive disease following HLA-identieal sibling bone marrow transplantion for leukemia[J]. Bone Marrow Transvlant, 1996. 17: 75.
9Schegel P G. Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuos infusion of prostagalandin E1 and low dose heparin [J]. Ann Hematol,1998,76:37.
10Endo S,Kasai T,Inana K,et al.Evaluation of procalcition in levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness[J].Kansenshogaku Zasshi,1999,73∶197-204.
5Je-Hwan Lee,Seong-Jun Choi,Jung-Hee Lee,So-Eun Kim,Chan-Jeoung Park,Hyun-Sook Chi,Moo-Song Lee,Jung-Shin Lee,Woo-Kun Kim,Kyoo-Hyung Lee. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation[J] 2005,Annals of Hematology(5):321～330
